Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter D R Higgins

Showing results (181-190 of 246) with videos related to

Pageof 25
Sort By:
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|July 18, 2018
Tofacitinib Induction Therapy Reduces Symptoms Within 3 Days for Patients With Ulcerative ColitisStephen Hanauer, Remo Panaccione, Silvio Danese, et al.
Crohn'S & Colitis 360|March 31, 2023
Efficacy and Safety of Advanced Therapies for Moderately to Severely Active Ulcerative Colitis at Induction and Maintenance: An Indirect Treatment Comparison Using Bayesian Network Meta-analysisRemo Panaccione, Eric B Collins, Gil Y Melmed, et al.
European Journal of Gastroenterology & Hepatology|August 18, 2020
Mapping the relationships between inflammatory bowel disease and comorbid diagnoses to identify disease associationsAkbar K Waljee, Mohamed Noureldin, Jeffrey A Berinstein, et al.
Crohn'S & Colitis 360|February 5, 2024
Association of Bowel Urgency With Quality-of-Life Measures in Patients With Moderately-to-Severely Active Ulcerative Colitis: Results From Phase 3 LUCENT-1 (Induction) and LUCENT-2 (Maintenance) StudiesMillie D Long, Stefan Schreiber, Toshifumi Hibi, et al.
Plos One|December 27, 2022
Understanding clinician connections to inform efforts to promote high-quality inflammatory bowel disease careShirley Cohen-Mekelburg, Tony Van, Xianshi Yu, et al.
Journal of Patient-Reported Outcomes|June 12, 2018
Development and validation of the Ulcerative Colitis patient-reported outcomes signs and symptoms (UC-pro/SS) diaryPeter D R Higgins, Gale Harding, Dennis A Revicki, et al.
Cellular and Molecular Gastroenterology and Hepatology|August 15, 2018
A Method for Cryogenic Preservation of Human Biopsy Specimens and Subsequent Organoid CultureYu-Hwai Tsai, Michael Czerwinski, Angeline Wu, et al.
The International Journal of Biochemistry & Cell Biology|November 2, 2011
Survivin expression induced by endothelin-1 promotes myofibroblast resistance to apoptosisJeffrey C Horowitz, Iyabode O Ajayi, Priya Kulasekaran, et al.
JAMA Network Open|September 5, 2020
Association of Continuity of Care With Outcomes in US Veterans With Inflammatory Bowel DiseaseShirley Cohen-Mekelburg, Sameer D Saini, Sarah L Krein, et al.
Advances in Bioscience and Biotechnology (Print)|January 29, 2013
Increased survivin expression contributes to apoptosis-resistance in IPF fibroblastsThomas H Sisson, Toby M Maher, Iyabode O Ajayi, et al.
Pageof 25

Showing results (181-190 of 246) with videos related to

Sort By:
Pageof 25
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|July 18, 2018
Tofacitinib Induction Therapy Reduces Symptoms Within 3 Days for Patients With Ulcerative ColitisStephen Hanauer, Remo Panaccione, Silvio Danese, et al.
Crohn'S & Colitis 360|March 31, 2023
Efficacy and Safety of Advanced Therapies for Moderately to Severely Active Ulcerative Colitis at Induction and Maintenance: An Indirect Treatment Comparison Using Bayesian Network Meta-analysisRemo Panaccione, Eric B Collins, Gil Y Melmed, et al.
European Journal of Gastroenterology & Hepatology|August 18, 2020
Mapping the relationships between inflammatory bowel disease and comorbid diagnoses to identify disease associationsAkbar K Waljee, Mohamed Noureldin, Jeffrey A Berinstein, et al.
Crohn'S & Colitis 360|February 5, 2024
Association of Bowel Urgency With Quality-of-Life Measures in Patients With Moderately-to-Severely Active Ulcerative Colitis: Results From Phase 3 LUCENT-1 (Induction) and LUCENT-2 (Maintenance) StudiesMillie D Long, Stefan Schreiber, Toshifumi Hibi, et al.
Plos One|December 27, 2022
Understanding clinician connections to inform efforts to promote high-quality inflammatory bowel disease careShirley Cohen-Mekelburg, Tony Van, Xianshi Yu, et al.
Journal of Patient-Reported Outcomes|June 12, 2018
Development and validation of the Ulcerative Colitis patient-reported outcomes signs and symptoms (UC-pro/SS) diaryPeter D R Higgins, Gale Harding, Dennis A Revicki, et al.
Cellular and Molecular Gastroenterology and Hepatology|August 15, 2018
A Method for Cryogenic Preservation of Human Biopsy Specimens and Subsequent Organoid CultureYu-Hwai Tsai, Michael Czerwinski, Angeline Wu, et al.
The International Journal of Biochemistry & Cell Biology|November 2, 2011
Survivin expression induced by endothelin-1 promotes myofibroblast resistance to apoptosisJeffrey C Horowitz, Iyabode O Ajayi, Priya Kulasekaran, et al.
JAMA Network Open|September 5, 2020
Association of Continuity of Care With Outcomes in US Veterans With Inflammatory Bowel DiseaseShirley Cohen-Mekelburg, Sameer D Saini, Sarah L Krein, et al.
Advances in Bioscience and Biotechnology (Print)|January 29, 2013
Increased survivin expression contributes to apoptosis-resistance in IPF fibroblastsThomas H Sisson, Toby M Maher, Iyabode O Ajayi, et al.
Pageof 25